Filter
637
Filtered Results: 637
Text search:
Thomson,
R.
Featured
Recommendations
47
New Publications
87
Language
Document type
No document type
332
Studies & Reports
150
Guidelines
90
Manuals
34
Fact sheets
12
Training Material
9
Strategic & Response Plan
9
Situation Updates
1
Countries / Regions
Global
33
India
15
Russia
14
Western and Central Europe
12
Kenya
9
Germany
9
South Africa
9
Sierra Leone
8
Mozambique
8
Latin America and the Carribbean
8
Eastern Europe
7
Brazil
7
Ukraine
6
Benin
6
Africa
6
Middle East and North Africa
6
Ethiopia
6
Cameroon
5
Senegal
5
Burkina Faso
5
Malawi
5
Philippines
5
Venezuela
5
Indonesia
5
Argentina
4
Uganda
4
Mali
4
Somalia
4
Liberia
4
Myanmar / Burma
4
Nepal
3
China
3
Chile
3
Syria
3
Nigeria
3
Guinea
3
Asia
3
Colombia
2
Thailand
2
Rwanda
2
Niger
2
Qatar
2
Jordan
2
Congo, Democratic Republic of
2
South–East Asia Region
2
Paraguay
2
North America
2
United Kingdom
2
Spain
2
Israel
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Bangladesh
2
Egypt
2
Sudan
2
Yemen
2
Romania
2
Chad
2
Botswana
2
Zambia
2
Mexico
1
El Salvador
1
Lesotho
1
Kazakhstan
1
Estonia
1
Congo-Brazzaville
1
Peru
1
Zimbabwe
1
Morocco
1
Mauritania
1
Armenia
1
USA
1
Haiti
1
Cambodia
1
Dominican Republic
1
Saudi Arabia
1
West and Central Africa
1
France
1
Tunisia
1
Portugal
1
Belarus
1
East and Southern Africa
1
Lebanon
1
Nicaragua
1
Namibia
1
Honduras
1
Libya
1
Iraq
1
Ecuador
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
133
Clinical Guidelines
60
Public Health
48
Women & Child Health
34
Key Resources
13
Pharmacy & Technologies
3
Capacity Building
1
Toolboxes
Mental Health
95
COVID-19
63
TB
60
HIV
57
Planetary Health
42
NCDs
30
Caregiver
24
AMR
22
Disability
17
NTDs
12
Rapid Response
11
Global Health Education
11
Refugee
9
Natural Hazards
9
Ebola
9
Pharmacy
6
Health Financing Toolbox
6
Polio
6
Social Ethics
4
Conflict
4
Specific Hazards
2
Zika
2
Cholera
1
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of a...
this Service Delivery brief provides evidence-based strategies that can help support drug shops and pharmacies in providing a wider variety of family planning methods and information. Evidence shows that with training and support, pharmacy and drug shop staff can facilitate the use of a broad range ...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
This interim guidance is for LTCF managers and corresponding infection prevention and control (IPC) focal persons in LTCF and updates the guidance published in March 2020. The objective of this document is to provide guidance on IPC in LTCFs in the context of COVID-19 to 1) prevent COVID-19-virus fr...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines ...
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog...
The paper provides the rationale for these recommendations, which are based on analyses of data from the TRACT trial.
Update 2021; Immunization, Vaccines and Biologicals
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
Int. J. Environ. Res. Public Health 2021, 18(24), 13339; https://doi.org/10.3390/ijerph182413339
The climate crisis threatens to exacerbate numerous climate-sensitive health risks, including heatwave mortality, malnutrition from reduced crop yields, water- and vector-borne infectious diseases, and...
doi: https://doi.org/10.1101/2020.11.30.20236570
Pre-Print Article
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
Cadre pour la planification, l'ebaoration et la mise en oeuvre de solutions avec et pour les jeunes e
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в
оказа...
Analysis of fake news disseminated during the COVID-19 pandemic in Brazil
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ...
Climate Change 2021: The Physical Science Basis. Contribution of Working Group I to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change
